Scientific publications

Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors

Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies

The SWI/SNF complex in cancer – biology, biomarkers and therapy

SWI/SNF Chromatin Remodeling and Human Malignancies

SWI/SNF complex-deficient soft tissue neoplasms: An update

Epigenetic Combination Therapy Could Overcome Treatment Resistance in Epithelioid Sarcomas and Rhabdoid Tumors

Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas

SWI/SNF-deficient Malignancies: Optimal Candidates for Immune-oncological Therapy?

Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy

Emerging role of SWI/SNF complex deficiency as a target of immune checkpoint blockade in human cancers

Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas

Immunotherapy for SMARCB1-deficient sarcomas: current evidence and future developments

SMARCB1/INI1-deficient tumors of adulthood

SMARCB1-deficient Tumors of Childhood: A Practical Guide

Stains & CD markers INI1 / SMARCB1

Gene of the month: SMARCB1

SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities

Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF